IQV IQVIA HOLDINGS INC.

NEUTRAL Impact: 3/10 8-K
Horizon immediate Filed Jun 11, 2026 Processed 5d 11h ago SEC 0001193125-26-267763
8-K material event: Items 1.01
Latest settled — T+1d
IQV ▼ -1.69% at T+1d
NEUTRAL call ✗ call lost -1.69% · α vs SPY -3.46% · entry $181.46 → $178.39
Next anchor: T+5d tomorrow
Currently $179.17 · -1.26% from $181.46 entry
Entry anchored
Jun 11, 03:59 PM ET
via Databento tick
T+1d
-1.69%
call -1.69% · α -3.46%
$178.39
settled 5d ago
T+5d
call — · α —
tomorrow
T+20d
call — · α —
in 23d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

IQVIA Inc., a wholly-owned subsidiary of IQVIA Holdings Inc., completed the issuance and sale of €950,000,000 in aggregate principal amount of 4.625% Senior Notes due 2033. The proceeds will be used to refinance certain existing indebtedness and pay related fees and expenses. This is a routine liability management transaction with no earnings or operational impact.

Actionable Insight

This is a routine refinancing that extends IQVIA's debt maturity profile. Monitor for any subsequent debt reduction or changes to leverage ratios. The notes are now outstanding and will add to total debt, but offset by repayment of existing obligations.

Key Facts

  • Issued €950,000,000 in 4.625% senior unsecured notes due June 15, 2033.
  • Interest payable semi-annually on June 15 and December 15, beginning December 15, 2026.
  • Proceeds used to refinance certain existing indebtedness of IQVIA Inc.
  • Notes are unsecured and rank equally with other senior unsecured indebtedness.
  • Issuer may redeem notes prior to June 15, 2029 at make-whole premium; thereafter at declining call premiums.
  • Certain subsidiaries of IQVIA Inc. guarantee the notes.

Financial Impact

€950,000,000 in gross proceeds; net proceeds used to refinance existing debt and pay offering expenses.

debtinterest expense

Risk Factors

  • Increased total leverage if proceeds are not entirely used to repay existing debt.
  • Interest expense will rise from the new notes at 4.625% depending on the rate of refinanced debt.

Market Snapshot

Exchange
NYSE
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
80% bullish (30 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-267763
Document: d157492d8k.htm0001193125-26-267763
Document: 0001193125-26-267763-index-headers.html0001193125-26-267763
Document: 0001193125-26-267763-index.html0001193125-26-267763
Document: 0001193125-26-267763.txt0001193125-26-267763
4 reports for IQV
Performance horizon
Filters
Rows
Reports for IQV — sortable, filterable
Type Now
Jun 11, 2026
5d ago
8-K
NEUTRAL ★ 3/10
$181.46 $178.39▼ −1.69%▼ −3.46%$179.17 (−1.26%)
Jun 4, 2026
12d ago
8-K
NEUTRAL ★ 3/10
$183.45 $183.69▲ +0.13%▼ −0.10%$179.17 (−2.33%)
Jun 3, 2026
13d ago
8-K
NEUTRAL ★ 3/10
$186.85 $183.33▼ −1.88%▲ +0.71%$179.17 (−4.11%)
Feb 27, 2026
15w ago
DEFA14A
NEUTRAL ★ 3/10
$174.24 $173.93▼ −0.18%▲ +0.74%$179.17 (+2.83%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 5h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access